{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:16:14Z","timestamp":1781795774277,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Pediatric diffuse gliomas (pDGs) are relatively rare and molecularly distinct from pediatric pilocytic astrocytoma and adult DGs. Immunotherapy is a promising therapeutic strategy, requiring a deep understanding of tumor immune profiles. The spatial locations of brain tumors might be related to the molecular profiles. We aimed to analyze the relationship between the immune checkpoint molecules with the locations of DGs comparing pediatric with adult patients.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> We studied 20 pDGs patients (age \u2264 21 years old), and 20 paired adult patients according to gender and histological types selected from 641 adult patients with DGs. Immune checkpoint molecules including B7-H3, CD47, and PD-L1, as well as tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs), were manifested by immunohistochemical staining. Expression difference analyses and Spearman's correlation were performed. MRI data were voxel-wise normalized, segmented, and analyzed by Fisher's exact test to construct the tumor frequency and p value heatmaps. Survival analyses were conducted by Log-rank tests.<\/jats:p><jats:p><jats:bold>Result:<\/jats:bold> The median age of pediatric patients was 16 years. 55% and 30% of patients were WHO II and III grades, respectively. The left frontal lobe and right cerebellum were the statistically significant locations for pDGs, while the anterior horn of ventricles for adult DGs. A potential association between the expression of PD-L1 and TAMs was found in pDGs (p = 0.002, R = 0.670). The right posterior external capsule and the lateral side of the anterior horn of the left ventricle were predominant locations for the adult patients with high expression of B7-H3 and low expression of PD-L1 compared to pediatric ones, respectively. Pediatric patients showed significantly improved overall survival compared with adults. The prognostic roles of immune checkpoint molecules and TILs\/TAMs were not significantly different between the two groups.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Immune checkpoint-associated locations of diffuse gliomas comparing pediatric with adult patients could be helpful for the immunotherapy decisions and design of clinical trials.<\/jats:p>","DOI":"10.3389\/fimmu.2021.582594","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T06:05:37Z","timestamp":1615961137000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Immune Checkpoint-Associated Locations of Diffuse Gliomas Comparing Pediatric With Adult Patients Based on Voxel-Wise Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangqi","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Iranmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/path.5457","article-title":"Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy","author":"Cacciotti","year":"2020","journal-title":"J Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ijrobp.2018.11.004","article-title":"Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children's Oncology Group Phase 2 Study ACNS0221","volume":"103","author":"Cherlow","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/neuonc\/now101","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nox141","article-title":"Pediatric low-grade gliomas: next biologically driven steps","volume":"20","author":"Jones","year":"2018","journal-title":"Neuro Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-018-1874-3","article-title":"Pediatric low-grade gliomas can be molecularly stratified for risk","volume":"136","author":"Yang","year":"2018","journal-title":"Acta Neuropathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e27063","DOI":"10.1002\/pbc.27063","article-title":"Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis","volume":"65","author":"Sadighi","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2015.11.FOCUS15530","article-title":"Beneficial impact of high-field intraoperative magnetic resonance imaging on the efficacy of pediatric low-grade glioma surgery","volume":"40","author":"Roder","year":"2016","journal-title":"Neurosurg Focus."},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-019-03133-y","article-title":"Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium","volume":"143","author":"Ceschin","year":"2019","journal-title":"J Neurooncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-019-03154-7","article-title":"Evaluation of pediatric glioma outcomes using intraoperative MRI: a multicenter cohort study","volume":"143","author":"Karsy","year":"2019","journal-title":"J Neurooncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/neuonc\/nou321","article-title":"Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in Finland","volume":"17","author":"Gunn","year":"2015","journal-title":"Neuro Oncol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.it.2019.05.009","article-title":"Towards Immunotherapy for Pediatric Brain Tumors","volume":"40","author":"Wang","year":"2019","journal-title":"Trends Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijrobp.2019.01.078","article-title":"Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma","volume":"104","author":"Indelicato","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.neuroimage.2011.09.076","article-title":"Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas","volume":"59","author":"Ellingson","year":"2012","journal-title":"Neuroimage."},{"key":"B18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3174\/ajnr.A3253","article-title":"Probabilistic radiographic atlas of glioblastoma phenotypes","volume":"34","author":"Ellingson","year":"2013","journal-title":"AJNR Am J Neuroradiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/jcm7070172","article-title":"Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer","volume":"7","author":"Inamura","year":"2018","journal-title":"J Clin Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/jnen\/nlz120","article-title":"Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes","volume":"79","author":"Pi Castro","year":"2020","journal-title":"J Neuropathol Exp Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12885-018-4457-8","article-title":"M1 macrophage recruitment correlates with worse outcome in SHH Medulloblastomas","volume":"18","author":"Lee","year":"2018","journal-title":"BMC Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jns.2019.03.028","article-title":"Characteristics, survival and incidence rates and trends of pilocytic astrocytoma in children in the United States; SEER-based analysis","volume":"400","author":"Tabash","year":"2019","journal-title":"J Neurol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/bjc.2013.404","article-title":"Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma","volume":"109","author":"Karremann","year":"2013","journal-title":"Br J Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","article-title":"Human glioblastoma arises from subventricular zone cells with low-level driver mutations","volume":"560","author":"Lee","year":"2018","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","article-title":"B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production","volume":"2","author":"Chapoval","year":"2001","journal-title":"Nat Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/cr.2017.90","article-title":"Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function","volume":"27","author":"Lee","year":"2017","journal-title":"Cell Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ebiom.2019.08.030","article-title":"B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres","volume":"47","author":"Nehama","year":"2019","journal-title":"EBioMedicine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1137","DOI":"10.1002\/cti2.1137","article-title":"Bioactivity and safety of B7-H3-targeted chimeric antigen receptor T cells against anaplastic meningioma","volume":"9","author":"Tang","year":"2020","journal-title":"Clin Transl Immunology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1391973","DOI":"10.1080\/2162402X.2017.1391973","article-title":"Blocking the CD47-SIRPalpha axis by delivery of anti-CD47 antibody induces antitumor effects in glioma and glioma stem cells","volume":"7","author":"Li","year":"2018","journal-title":"Oncoimmunology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"eaaf2968","DOI":"10.1126\/scitranslmed.aaf2968","article-title":"Disrupting the CD47-SIRP\u03b1 anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors","volume":"9","author":"Gholamin","year":"2017","journal-title":"Sci Transl Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science."},{"key":"B33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/neuonc\/nov172","article-title":"PD-L1 expression and prognostic impact in glioblastoma","volume":"18","author":"Nduom","year":"2016","journal-title":"Neuro Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2019.01.018","article-title":"Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer","volume":"111","author":"Yagi","year":"2019","journal-title":"Eur J Cancer."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","article-title":"Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer","volume":"68","author":"Lin","year":"2019","journal-title":"Gut."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/cncr.30724","article-title":"Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues","volume":"123","author":"Majzner","year":"2017","journal-title":"Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"noaa278","DOI":"10.1093\/neuonc\/noaa278","article-title":"Cell surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery","volume":"15","author":"Haydar","year":"2020","journal-title":"Neuro Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.tranon.2019.11.006","article-title":"B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors","volume":"13","author":"Maachani","year":"2020","journal-title":"Transl Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41593-018-0285-z","article-title":"Invasion of white matter tracts by glioma stem cells is regulated by a NOTCH1-SOX2 positive-feedback loop","volume":"22","author":"Wang","year":"2019","journal-title":"Nat Neurosci."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.582594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T06:05:40Z","timestamp":1615961140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.582594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2021.582594"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.582594","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"article-number":"582594"}}